75F40123C00073
Definitive Contract
Overview
Government Description
UEI: HCWKVFGBPA64
LABOR HOUR AWARD
CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) OFFICE OF NEW DRUGS (OND) - WRITER/EDITOR SUPPORT SERVICES
COR: NIKISHA REID PHONE: 240-402-9741, NIKISHA.REID@FDA.HHS.GOV
NOTICE TO PROCEED WAS ISSUED ON 05/30
Awardee
Awarding / Funding Agency
Place of Performance
Rockville, MD 20857 United States
Pricing
Labor Hours
Set Aside
None
Extent Competed
Not Available For Competition
Related Opportunity
None
Analysis Notes
COVID-19 $1,171,895 (16%) percent of this Definitive Contract was funded by COVID-19 emergency acts including the American Rescue Plan Act of 2021.
Amendment Since initial award the Potential End Date has been extended from 11/30/24 to 12/10/24.
Sole Source This Definitive Contract was awarded sole source to Kaiva Strategies because the government was authorized to sole source the contract by statute.
Amendment Since initial award the Potential End Date has been extended from 11/30/24 to 12/10/24.
Sole Source This Definitive Contract was awarded sole source to Kaiva Strategies because the government was authorized to sole source the contract by statute.
Kaiva Strategies was awarded
Definitive Contract 75F40123C00073 (75F401-23-C-00073)
worth up to $9,999,433
by the FDA Office of Acquisition and Grant Services
in September 2023.
The contract
has a duration of 1 year 3 months and
was awarded
full & open
with
NAICS 541690 and
PSC R406
via sole source acquisition procedures with 1 bid received.
As of today, the Definitive Contract has a total reported backlog of $2,644,453.
Status
(Open)
Last Modified 10/31/24
Period of Performance
9/5/23
Start Date
12/10/24
Current End Date
12/10/24
Potential End Date
Obligations and Backlog
$7.4M
Total Obligated
$7.4M
Current Award
$10.0M
Potential Award
$0.0
Funded Backlog
$2.6M
Total Backlog
Award Hierarchy
Definitive Contract
75F40123C00073
Subcontracts
Activity Timeline
Labor Services Billing
Annual labor billing rates and FTE reported for 75F40123C00073
| Year | Services Invoiced | Hours | FTE | Blended Rate |
|---|---|---|---|---|
| 2023 | $1,258,661 | 13,764.5 | 6.6 | $91.44 |
Transaction History
Modifications to 75F40123C00073
People
Suggested agency contacts for 75F40123C00073
Competition
Number of Bidders
1
Solicitation Procedures
Sole Source
Other Than Full and Open Competition
Authorized By Statute
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
HCWKVFGBPA64
Awardee CAGE
99AZ4
Agency Detail
Awarding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Funding Office
75F401
Created By
hhskdavis2
Last Modified By
hhskdavis2
Approved By
hhskdavis2
Legislative
Legislative Mandates
None Applicable
Performance District
MD-08
Senators
Benjamin Cardin
Chris Van Hollen
Chris Van Hollen
Representative
Jamie Raskin
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Salaries and Expenses, Food and Drug Administration, Health and Human Services (075-0600) | Consumer and occupational health and safety | Other services from non-Federal sources (25.2) | $2,437,541 | 100% |
Modified: 10/31/24